Literature search services are currently unavailable. During our hosting provider's UPS upgrade we experienced a hardware failure and are currently working to resolve the issue.

Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.

To elucidate the role of the synaptic protein alpha-synuclein in neurodegenerative disorders, transgenic mice expressing wild-type human alpha-synuclein were generated. Neuronal expression of human alpha-synuclein resulted in progressive accumulation of alpha-synuclein-and ubiquitin-immunoreactive inclusions in neurons in the neocortex, hippocampus, and substantia nigra. Ultrastructural analysis revealed both electron-dense intranuclear deposits and cytoplasmic inclusions. These alterations were associated with loss of dopaminergic terminals in the basal ganglia and with motor impairments. These results suggest that accumulation of wild-type alpha-synuclein may play a causal role in Parkinson's disease and related conditions.

Pubmed ID: 10678833


  • Masliah E
  • Rockenstein E
  • Veinbergs I
  • Mallory M
  • Hashimoto M
  • Takeda A
  • Sagara Y
  • Sisk A
  • Mucke L


Science (New York, N.Y.)

Publication Data

February 18, 2000

Associated Grants

  • Agency: NIA NIH HHS, Id: AG10689
  • Agency: NIA NIH HHS, Id: AG11385
  • Agency: NIA NIH HHS, Id: AG5131

Mesh Terms

  • Animals
  • Brain
  • Dopamine
  • Humans
  • Inclusion Bodies
  • Lewy Bodies
  • Lewy Body Disease
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred DBA
  • Mice, Transgenic
  • Microscopy, Electron
  • Motor Activity
  • Nerve Tissue Proteins
  • Neurodegenerative Diseases
  • Neurons
  • Substantia Nigra
  • Synucleins
  • Tyrosine 3-Monooxygenase
  • Ubiquitins
  • alpha-Synuclein